The role of protein post-translational modifications in prostate cancer

被引:1
作者
Hao, Yinghui [1 ]
Gu, Chenqiong [1 ]
Luo, Wenfeng [1 ]
Shen, Jian [1 ]
Xie, Fangmei [1 ]
Zhao, Ying [1 ]
Song, Xiaoyu [1 ]
Han, Zeping [1 ]
He, Jinhua [1 ,2 ]
机构
[1] Guangzhou Med Univ, Affiliated Guangzhou Panyu Cent Hosp, Cent Lab, Guangzhou, Peoples R China
[2] Rehabil Med Inst Panyu Dist, Guangzhou, Guangdong, Peoples R China
来源
PEERJ | 2024年 / 12卷
关键词
Protein post-translational modification; Prostate cancer; Diagnosis; Treatment; Prognosis; DOCETAXEL RESISTANCE; DIAGNOSIS; GLYCOSYLATION; EXPRESSION; PATHWAY; PHOSPHORYLATION; TRANSCRIPTION; PROGRESSION; SUPPRESSES; BIOMARKER;
D O I
10.7717/peerj.17768
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Involving addition of chemical groups or protein units to specific residues of the target protein, post-translational modifications (PTMs) alter the charge, hydrophobicity, and conformation of a protein, which in turn influences protein function, protein-protein interaction, and protein aggregation. These alterations, which include phosphorylation, glycosylation, ubiquitination, methylation, acetylation, lipidation, and lactylation, are significant biological events in the development of cancer, and play vital roles in numerous biological processes. The processes behind essential functions, the screening of clinical illness signs, and the identification of therapeutic targets all depend heavily on further research into the PTMs. This review outlines the influence of several PTM types on prostate cancer (PCa) diagnosis, therapy, and prognosis in an effort to shed fresh light on the molecular causes and progression of the disease.
引用
收藏
页数:28
相关论文
共 148 条
[21]   ERK1/2 inhibits Cullin 3/SPOP-mediated PrLZ ubiquitination and degradation to modulate prostate cancer progression [J].
Fan, Yizeng ;
Hou, Tao ;
Dan, Weichao ;
Zhu, Yasheng ;
Liu, Bo ;
Wei, Yi ;
Wang, Zixi ;
Gao, Yang ;
Zeng, Jin ;
Li, Lei .
CELL DEATH AND DIFFERENTIATION, 2022, 29 (08) :1611-1624
[22]   Acetylation-dependent regulation of TPD52 isoform 1 modulates chaperone-mediated autophagy in prostate cancer [J].
Fan, Yizeng ;
Hou, Tao ;
Gao, Yang ;
Dan, Weichao ;
Liu, Tianjie ;
Liu, Bo ;
Chen, Yule ;
Xie, Hongjun ;
Yang, Zhao ;
Chen, Jiaqi ;
Zeng, Jin ;
Li, Lei .
AUTOPHAGY, 2021, 17 (12) :4386-4400
[23]   OTUD6A promotes prostate tumorigenesis via deubiquitinating Brg1 and AR [J].
Fu, Xuhong ;
Zhao, Junjie ;
Yu, Guopeng ;
Zhang, Xiaomin ;
Sun, Jie ;
Li, Lingmeng ;
Yin, Jingyi ;
Niu, Yinan ;
Ren, Shancheng ;
Zhu, Yasheng ;
Xu, Bin ;
Huang, Liyu .
COMMUNICATIONS BIOLOGY, 2022, 5 (01)
[24]   Lipid pathway deregulation in advanced prostate cancer [J].
Galbraith, Laura ;
Leung, Hing Y. ;
Ahmad, Imran .
PHARMACOLOGICAL RESEARCH, 2018, 131 :177-184
[25]   Speckle-type POZ protein suppresses lipid accumulation and prostate cancer growth by stabilizing fatty acid synthase [J].
Gang, Xiaokun ;
Xuan, Lili ;
Zhao, Xue ;
Lv, You ;
Li, Fei ;
Wang, Yao ;
Wang, Guixia .
PROSTATE, 2019, 79 (08) :864-871
[26]   KIF15-Mediated Stabilization of AR and AR-V7 Contributes to Enzalutamide Resistance in Prostate Cancer [J].
Gao, Lin ;
Zhang, Wenbo ;
Zhang, Jing ;
Liu, Junmei ;
Sun, Feifei ;
Liu, Hui ;
Hu, Jing ;
Wang, Xin ;
Wang, Xueli ;
Su, Peng ;
Chen, Shouzhen ;
Qu, Sifeng ;
Shi, Benkang ;
Xiong, Xueting ;
Chen, Weiwen ;
Dong, Xuesen ;
Han, Bo .
CANCER RESEARCH, 2021, 81 (04) :1026-1039
[27]   ErbB2 Signaling Increases Androgen Receptor Expression in Abiraterone-Resistant Prostate Cancer [J].
Gao, Shuai ;
Ye, Huihui ;
Gerrin, Sean ;
Wang, Hongyun ;
Sharma, Ankur ;
Chen, Sen ;
Patnaik, Akash ;
Sowalsky, Adam G. ;
Voznesensky, Olga ;
Han, Wanting ;
Yu, Ziyang ;
Mostaghel, Elahe A. ;
Nelson, Peter S. ;
Taplin, Mary-Ellen ;
Balk, Steven P. ;
Cai, Changmeng .
CLINICAL CANCER RESEARCH, 2016, 22 (14) :3672-3682
[28]   ST6GAL1: A key player in cancer [J].
Garnham, Rebecca ;
Scott, Emma ;
Livermore, Karen E. ;
Munkley, Jennifer .
ONCOLOGY LETTERS, 2019, 18 (02) :983-989
[29]   USP16 regulates castration-resistant prostate cancer cell proliferation by deubiquitinating and stablizing c-Myc [J].
Ge, Jianchao ;
Yu, Wandong ;
Li, Junhong ;
Ma, Hangbin ;
Wang, Pengyu ;
Zhou, Yinghao ;
Wang, Yang ;
Zhang, Jun ;
Shi, Guowei .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40 (01)
[30]   Protein diversification through post-translational modifications, alternative splicing, and gene duplication [J].
Goldtzvik, Yonathan ;
Sen, Neeladri ;
Lam, Su Datt ;
Orengo, Christine .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 2023, 81